Compounds for treating Huntington's disease
US-12577226-B2 · Mar 17, 2026 · US
This page is not indexed by search engines while we improve data quality.
Karp Gary Mitchell patents
Karp Gary Mitchell is listed as an inventor on 53 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Karp Gary Mitchell |
| Total patents | 53 |
| First publication | Jan 1, 2015 |
| Latest publication | Mar 17, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Heterocyclic and heteroaryl compounds for treating huntington's disease
US-2026028347-A1 · Jan 29, 2026 · US
Substituted pyrrolo [2,3-d]pyrimidines for treating familial dysautonomia
US-12398140-B2 · Aug 26, 2025 · US
Thioeno[3,2-b] pyridin-7-amine compounds for treating familial dysautonomia
US-12384797-B2 · Aug 12, 2025 · US
Compounds for treating Huntington's disease
US-12384789-B2 · Aug 12, 2025 · US
Heteroaryl compounds for treating Huntington's disease
US-12139499-B2 · Nov 12, 2024 · US
Heteroaryl compounds for treating huntington's disease
US-2024336613-A1 · Oct 10, 2024 · US
Heterocyclic and heteroaryl compounds for treating huntington's disease
US-2024132509-A1 · Apr 25, 2024 · US
Compounds for treating spinal muscular atrophy
US-2024067646-A1 · Feb 29, 2024 · US
Methods for treating spinocerebellar ataxia type 3
US-2024051968-A1 · Feb 15, 2024 · US
Recent patents
Latest publications not already listed above.
Methods for treating spinocerebellar ataxia type 3
US-2024041886-A1 · Feb 8, 2024 · US
Methods for treating spinocerebellar ataxia type 3
US-2024043444-A1 · Feb 8, 2024 · US
Heterocyclic and heteroaryl compounds for treating Huntington's disease
US-11858941-B2 · Jan 2, 2024 · US
Compounds for treating huntington's disease
US-2023331725-A1 · Oct 19, 2023 · US
Compounds for treating Huntington's disease
US-11780839-B2 · Oct 10, 2023 · US
Compounds for treating spinal muscular atrophy
US-11753407-B2 · Sep 12, 2023 · US
Compounds for treating huntington's disease
US-2023234942-A1 · Jul 27, 2023 · US
Heteroaryl compounds for treating Huntington's disease
US-11685746-B2 · Jun 27, 2023 · US
Compounds for treating familial dysautonomia
US-2023057568-A1 · Feb 23, 2023 · US
Compounds for treating huntington's disease
US-2022251098-A1 · Aug 11, 2022 · US
Compounds for treating Huntington's disease
US-11407753-B2 · Aug 9, 2022 · US
Compounds for treating huntington's disease
US-2022204478-A1 · Jun 30, 2022 · US
Thioeno[3,2-b] pyridin-7-amine compounds for treating familial dysautonomia
US-2022135586-A1 · May 5, 2022 · US
Pyrrolo[2,3-d]pyrimidine compounds for treating familial dysautonomia
US-2022135568-A1 · May 5, 2022 · US
Heteroaryl compounds for treating huntington's disease
US-2021380603-A1 · Dec 9, 2021 · US
Heteroaryl compounds for treating huntington's disease
US-2021284660-A1 · Sep 16, 2021 · US
Compounds for treating spinal muscular atrophy
US-2021276999-A1 · Sep 9, 2021 · US
Heterocyclic and heteroaryl compounds for treating huntington's disease
US-2021238186-A1 · Aug 5, 2021 · US
Compounds for treating huntington's disease
US-2021024525-A1 · Jan 28, 2021 · US
Compounds for treating spinal muscular atrophy
US-10851101-B2 · Dec 1, 2020 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Ptc Therapeutics Inc | 61 |
| Hoffmann La Roche | 15 |
| F Hoffmann—La Roche Ag | 1 |
| F Hoffmann La Roche | 1 |
| Maccoss Malcolm | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07D487/04 | 36 |
| A61P25/00 | 29 |
| C07D471/04 | 29 |
| C07D519/00 | 27 |
| A61P25/28 | 25 |